Changes in the gene expression of specific G-protein subunits correlate with morphine insensitivity in streptozotocin-induced diabetic rats

Neuropeptides

Volumn 44, Issue 4, 2010, Pages 299-304

  Hajializadeh, Zahra ^a   Esmaeili Mahani, Saeed ^b   Sheibani, Vahid ^a   Kaeidi, Ayat ^c   Atapour, Manijeh ^a   Abbasnejad, Mehdi ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analgesia; Diabetes; G proteins; Gene expression; Morphine; Rats

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HUMAN INSULIN; MESSENGER RNA; MORPHINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL COMPOSITION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG SENSITIVITY; EVENING DOSAGE; GENE EXPRESSION PROFILING; IMMUNOBLOTTING; INSULIN TREATMENT; LUMBAR SPINAL CORD; MALE; MORNING DOSAGE; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TAIL FLICK TEST; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE; GENE EXPRESSION; GTP-BINDING PROTEINS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MORPHINE; NERVE TISSUE PROTEINS; PAIN MEASUREMENT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953540504     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.02.004     Document Type: Article

References (34)

1. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Short Protocols in Molecular Biology 2002, Wiley, USA.
2. Campagnoni A.T., Verdi J.M., Verity A.N., Amur-Umarjee S., Byravan S. Posttranscriptional regulation of myelin protein gene expression. Ann. NY Acad. Sci. 1991, 633:178-188.
3. Chakrabarti S., Regec A., Gintzler A.R. Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. Brain Res. Mol. Brain Res. 2005, 135:217-224.
4. Chakrabarti S., Gintzler A.R. Phosphorylation of Galphas influences its association with the micro-opioid receptor and is modulated by long-term morphine exposure. Mol. Pharmacol. 2007, 72:753-760.
5. Chen S.R., Pan H.L. Antinociceptive effect of morphine, but not-opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 2003, 99:1409-1414.
6. Chen S.R., Sweigart K.L., Lakoski J.M., Pan H.L. Functional μ-opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 2002, 97:1602-1608.
7. D'Amour F.E., Smith D.L. A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 1941, 27:74-79.
8. Esmaeili-Mahani S., Javan M., Motamedi F., Ahmadiani A. Post-adrenalectomy changes in the gene expression of specific G-protein subunits involved in morphine sensitization. Neuropeptides 2008, 42:169-175.
9. +2 channels in rats. J. Neurosci. Res. 2008, 86:471-479.
10. i activity in diabetes. Nature 1987, 327:229-232.
11. Gul H., Yildiz O., Dogrul A., Yesilyurt O., Isimer A. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 2000, 89:39-45.
12. 2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats. Eur. J. Pharmacol. 2002, 435:187-194.
13. Hall K.E., Liu J., Sima A.F., Wiley J.W. Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy. J. Neurophysiol. 2001, 86:760-770.
14. Hashim S., Li Y., Nagakura A., Takeo S., Anand-Srivastava M.B. Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle. Cardiovasc. Res. 2004, 63:709-718.
15. Ibironke G.F., Saba O.J. Effect of hyperglycemia on the efficacy of morphine analgesia in rats. Afr. J. Med. Med. Sci. 2006, 35:443-445.
16. Javan M., Kazemi B., Ahmadiani A., Motamedi F. Dexamethasone mimics the inhibitory effect of chronic pain on the development of tolerance to morphine analgesia and compensates for morphine induced changes in G proteins gene expression. Brain Res. 2006, 1104:73-79.
17. Kamei J., Ohhashi Y., Aoki T., Kawasima N., Kasuya Y. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Brain Res. 1992, 571:199-203.
18. Karci A., Tasdogen A., Erkin Y., Aktas G., Elar Z. The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiol. Scand. 2004, 48:619-624.
19. Law P.Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 2000, 40:389-430.
20. Lutfy K., Chang S.C., Candido J., Jang Y., Sierra V., Yoburn B.C. Modification of morphine-induced analgesia and toxicity by pertussis toxin. Brain Res. 1991, 544:191-195.
21. Marone M., Mozzetti S., Ritis D.D., Pierelli L., Scambia G. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol. Proced. Online 2001, 3:19-25.
22. s protein expression in diabetic rat hearts. N-S Arch. Pharmacol. 2000, 361:53-60.
23. Morris A.J., Malbon C.C. Physiological regulation of G protein-linked signaling. Physiol. Rev. 1999, 79:1373-1430.
24. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47:24-32.
25. Rodgers B.D., Bernier M., Levine M.A. Endocrine regulation of G-protein subunit production in an animal model of type 2 diabetes mellitus. J. Endocrinol. 2001, 168:509-515.
26. Sanchez-Blazquez P., Garzon J. Cholera toxin and pertussis toxin on opioid- and alpha 2-mediated supraspinal analgesia in mice. Life Sci. 1991, 48:1721-1727.
27. Shen K.F., Crain S.M. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Res. 2001, 919:20-30.
28. Standifer K.M., Pasternak G.W. G-proteins and opioid receptor-mediated signaling. Cell Signal. 1997, 9:237-248.
29. Standifer K.M., Rossi G.C., Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol. Pharmacol. 1996, 50:293-298.
30. Tseng L.F., Collins K.A. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 1996, 279:39-46.
31. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 2001, 81:299-343.
32. Williams J.T., North R.A., Tokimasa T. Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J. Neurosci. 1988, 8:4299-4306.
33. Yaksh T.L., Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science 1976, 192:1357-1358.
34. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.